BEGIN:VCALENDAR
VERSION:2.0
CALSCALE:GREGORIAN
PRODID:iCalendar-Ruby
BEGIN:VEVENT
CATEGORIES:
DESCRIPTION:USC/CHLA Cell Therapy Program Seminar Series invites you to lea
 rn more about \n\nSecond-line (2L) standard-of-care (SOC) for large B-cell 
 lymphoma (LBCL)\n\nCD19 CAR-T for relapsed/refractory (R/R) LBCL (>2L)\n\nI
 mpact of the CD19 CAR product on outcomes of R/R LBCL\n\nCD19 CAR-T versus 
 SOC for 2L high-risk LBCL
DTEND:20221006T200000Z
DTSTAMP:20260417T084116Z
DTSTART:20221006T190000Z
LOCATION:
SEQUENCE:0
SUMMARY:CHLA/USC Cell Therapy Program Seminar Series - Jordan Gauthier: Adv
 ancing CAR T-cell therapy for high-risk B-NHL
UID:tag:localist.com\,2008:EventInstance_41130011351800
URL:https://calendar.usc.edu/event/chlausc_cell_therapy_program_seminar_ser
 ies_-_jordan_gauthier_advancing_car_t-cell_therapy_for_high-risk_b-nhl
END:VEVENT
END:VCALENDAR